Olli Vapalahti, University of Helsinki, Helsinki, Finland.
Zoonotic infections, BSL3 facilities and animal models for studying virus-host interactions.
Jari Koistinaho, University of Helsinki, Helsinki, Finland.
Brain infections and neurodegenerative diseases.
Anu Wartiovaara, University of Helsinki, Helsinki, Finland.
Metabolic changes during brain infection.
Vincenzo Cerullo, University of Helsinki, Helsinki, Finland.
Vaccine development and optimization.
Dario Greco, University of Tampere, Tampere, Finland.
Computational tools for drug discovery.
Antti Makitie & Sanna Salmi, Helsinki University Hospital, Helsinki, Finland.
Development of human 3D nasal epithelia.
Tom Kirchhausen, Harvard Medical School, Boston, USA.
Advanced imaging to study virus-host interaction.
Axel Brunger, Stanford University, Stanford, USA.
Structural biology for development of ultra-potent antiviral peptides.
Yohei Yamauci, ETH Zürich, Zürich, Switzerland.
Role of neuropilin receptors in virus infection and spreading.
Tambet Teesalu, University of Tartu, Tartu, Estonia.
The C-end rule of virus infection.
Guido Serini, University of Turin, Turin, Italy.
Physiological role of neuropilin receptors in endo- and epithelial cells.
Urs Greber, ETH Zürich, Zürich, Switzerland.
Virus cell entry.
Merja Joensuu, University of Queensland, Brisbane, Australia.
The secretory pathway and virus assembly and release.
Juan Polanco & Jurgen Götz, University of Queensland, Brisbane, Australia.
Intra- and intercellular trafficking of neurotoxic molecules.
Kirsty Short, University of Queensland, Brisbane, Australia.
Human and mouse models to study respiratory viruses